SEC Form D · filed January 21, 2025
Immunovant, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (26)
Andrew Fromkin · New York, NYDirectorFrank Torti · Mill Valley, CADirectorDouglas Hughes · New York, NYDirectorChristopher Van Tuyl · New York, NYExecMichael Geffner · New York, NYExecAtul Pande · New York, NYDirectorGeorge Migausky · New York, NYDirectorEric Venker · New York, NYDirectorPete Salzmann · New York, NYExec · DirectorJay Stout · New York, NYExecMelanie Gloria · New York, NYExecEva Renee Barnett · New York, NYExecBill Macias · New York, NYExecChristopher Van Tuyl · New York, NYExecMichael Geffner · New York, NYExecAndrew Fromkin · New York, NYDirectorAtul Pande · New York, NYDirectorGeorge Migausky · New York, NYDirectorEric Venker · New York, NYDirectorFrank Torti · Mill Valley, CADirectorPete Salzmann · New York, NYExec · DirectorJay Stout · New York, NYExecMelanie Gloria · New York, NYExecEva Renee Barnett · New York, NYExecBill Macias · New York, NYExecDouglas Hughes · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗